Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni D'Arena

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Investigation|December 1, 2015
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient responseCinzia Bologna, Roberta Buonincontri, Sara Serra, et al.
Frontiers in Oncology|December 16, 2020
CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical RelevanceGiovanni D'Arena, Vincenzo De Feo, Giuseppe Pietrantuono, et al.
Oncotargets and Therapy|August 28, 2020
Atypical Mature T-Cell Neoplasms: The Relevance of the Role of Flow CytometryTeodora Statuto, Fiorella D'Auria, Luigi Del Vecchio, et al.
Leukemia & Lymphoma|February 9, 2011
Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized studyGiovanni D'Arena, Paolo G Gobbi, Chiara Broglia, et al.
Oxidative Medicine and Cellular Longevity|March 16, 2016
Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric CarcinogenesisAldo Giudice, Giovanni D'Arena, Anna Crispo, et al.
Hematological Oncology|July 30, 2010
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemiaPietro Bulian, Michela Tarnani, Davide Rossi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 10, 2015
High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disordersAntonella Caivano, Ilaria Laurenzana, Luciana De Luca, et al.
Haematologica|January 19, 2023
The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergyFrancesca Arruga, Marta Rubin, Despoina Papazoglou, et al.
Molecular Therapy. Oncology|October 2, 2025
Complex genetic landscape in CLL: Clinical impact on patients' survival and insights into the altered molecular pathwaysCarlo Caputo, Massimo Donadelli, Mariateresa Scupoli, et al.
Cancers|January 26, 2024
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic StudyGiovanni D'Arena, Candida Vitale, Giuseppe Pietrantuono, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Investigation|December 1, 2015
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient responseCinzia Bologna, Roberta Buonincontri, Sara Serra, et al.
Frontiers in Oncology|December 16, 2020
CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical RelevanceGiovanni D'Arena, Vincenzo De Feo, Giuseppe Pietrantuono, et al.
Oncotargets and Therapy|August 28, 2020
Atypical Mature T-Cell Neoplasms: The Relevance of the Role of Flow CytometryTeodora Statuto, Fiorella D'Auria, Luigi Del Vecchio, et al.
Leukemia & Lymphoma|February 9, 2011
Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized studyGiovanni D'Arena, Paolo G Gobbi, Chiara Broglia, et al.
Oxidative Medicine and Cellular Longevity|March 16, 2016
Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric CarcinogenesisAldo Giudice, Giovanni D'Arena, Anna Crispo, et al.
Hematological Oncology|July 30, 2010
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemiaPietro Bulian, Michela Tarnani, Davide Rossi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 10, 2015
High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disordersAntonella Caivano, Ilaria Laurenzana, Luciana De Luca, et al.
Haematologica|January 19, 2023
The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergyFrancesca Arruga, Marta Rubin, Despoina Papazoglou, et al.
Molecular Therapy. Oncology|October 2, 2025
Complex genetic landscape in CLL: Clinical impact on patients' survival and insights into the altered molecular pathwaysCarlo Caputo, Massimo Donadelli, Mariateresa Scupoli, et al.
Cancers|January 26, 2024
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic StudyGiovanni D'Arena, Candida Vitale, Giuseppe Pietrantuono, et al.
Pageof 10